LongGame invests in early-stage biotech startups targeting ageing and life extension
Longevity Technology - 12-Dec-2024Focus areas include gene editing, stem cell therapies, and affordable health solutions
Join the club for FREE to access the whole archive and other member benefits.
Longevity-focused venture capital
LongGame is a forward-thinking venture capital firm established in 2024, dedicated to advancing radical lifespan extension through strategic investments. With a focus on scalable, scientifically backed solutions, LongGame aims to make longevity advancements accessible to society at large. The firm emphasizes integrity and robust evidence in its investment approach, supporting companies committed to transformative progress in life extension. Operating with a small but expert team, LongGame is driving efforts to create a future where extended, healthy lifespans are a reality for all.
L³ is a selective launchpad for early-stage companies advancing healthy lifespan extension through science, data, and technology. More details here: L³ Launchpad
Visit website: https://longgame.vc/
Details last updated 31-Jul-2026
Focus areas include gene editing, stem cell therapies, and affordable health solutions